Supplementary Figure S14 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell CarcinomaChang Gon Kim,Min Hee Hong,Dahee Kim,Brian Hyohyoung Lee,Hyunwook Kim,Chan-Young Ock,Geoffrey Kelly,Yoon Ji Bang,Gamin Kim, Jung Eun Lee,Chaeyeon Kim,Se-Heon Kim,Hyun Jun Hong,Young Min Park,Nam Suk Sim,Heejung Park,Jin Woo Park,Chang Geol Lee,Kyung Hwan Kim, Goeun Park,Inkyung Jung, Dawoon Han,Jong Hoon Kim, Junha Cha,Insuk Lee,Mingu Kang,Heon Song, Chiyoon Oum,Seulki Kim,Sukjun Kim,Yoojoo Lim,Seunghee Kim-Schulze,Miriam Merad,Sun Och Yoon,Hyun Je Kim,Yoon Woo Koh,Hye Ryun Kimcrossref（2024）引用 0|浏览8暂无评分摘要High-dimensional profiling of CD8+ T cells.更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
